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Abstract
Background: Exposure to mustard gas frequently results in long-term respiratory complications.
However the factors which drive the development and progression of these complications remain
unclear. The Renin Angiotensin System (RAS) has been implicated in lung inflammatory and fibrotic
responses. Genetic variation within the gene coding for the Angiotensin Converting Enzyme (ACE),
specifically the Insertion/Deletion polymorphism (I/D), is associated with variable levels of ACE and
with the severity of several acute and chronic respiratory diseases. We hypothesized that the ACE
genotype might influence the severity of late respiratory complications of mustard gas exposure.
Methods: 208 Kurdish patients who had suffered high exposure to mustard gas, as defined by
cutaneous lesions at initial assessment, in Sardasht, Iran on June 29 1987, underwent clinical
examination, spirometric evaluation and ACE Insertion/Deletion genotyping in September 2005.
Results:  ACE genotype was determined in 207 subjects. As a continuous variable, FEV1 %
predicted tended to be higher in association with the D allele 68.03 ± 20.5%, 69.4 ± 21.4% and 74.8
± 20.1% for II, ID and DD genotypes respectively. Median FEV1 % predicted was 73 and this was
taken as a cut off between groups defined as having better or worse lung function. The ACE DD
genotype was overrepresented in the better spirometry group (Chi2 4.9 p = 0.03). Increasing age
at the time of exposure was associated with reduced FEV1 %predicted (p = 0.001), whereas gender
was not (p = 0.43).
Conclusion: The ACE D allele is associated with higher FEV1 % predicted when assessed 18 years
after high exposure to mustard gas.
Published: 14 August 2008
BMC Pulmonary Medicine 2008, 8:15 doi:10.1186/1471-2466-8-15
Received: 8 October 2007
Accepted: 14 August 2008
This article is available from: http://www.biomedcentral.com/1471-2466/8/15
© 2008 Hosseini-khalili et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pulmonary Medicine 2008, 8:15 http://www.biomedcentral.com/1471-2466/8/15
Page 2 of 5
(page number not for citation purposes)
Background
Some 100,000 Iranians were exposed to chemical warfare
agents during the 8-year Iraq-Iran war, with the approxi-
mately 50,000 mustard gas-affected individuals exhibiting
a pattern of late respiratory, eye and skin complications
[1]. Chronic bronchitis, asthma, bronchiectasis and pul-
monary fibrosis account for the most frequent long-term
respiratory sequelae, with progressive decline occurring
over many years [2-5].
Mustard gas, bis (2- chloroethyl) sulphide, is a bifunc-
tional alkylating agent. It is a potent vesicant, whose rapid
penetration leads to extensive blistering in all epithelial
tissues exposed to it. The immediate toxicity of mustard
gas is thought to be due to the consequences of both DNA
and protein alkylation reactions [6]. However, the factors
which drive the development and progression of the long
term respiratory complications remain unclear.
The circulating or endocrine renin-angiotensin system
(RAS) plays a key role in circulatory homeostasis. Angi-
otensin Converting Enzyme (ACE) converts angiotensin I
to the potent vasoconstrictor angiotensin II. However,
local RAS exist in diverse human tissues, where they play
proinflammatory and profibrotic roles [7-9]. A lung RAS
is now known to exist and is implicated in the genesis of
lung inflammatory and fibrotic responses [10].
Whether in the circulation or the tissues [11,12], the
absence (deletion, D allele) rather than the presence
(insertion, I allele) of a 287 base pair fragment in the
human ACE gene is associated with increased ACE activ-
ity. In keeping with the postulated roles for ACE in the
lung, the D-allele has been associated with development
of the acute respiratory distress syndrome, and poorer
markers of respiratory function in acute illness [13,14].
However, such detrimental impact of the D-allele in acute
illness might be counterbalanced by more positive sys-
temic affects in chronic disease, as suggested by the associ-
ation of the D-allele with preserved skeletal muscle
strength amongst patients with chronic pulmonary dis-
ease [15].
We thus postulated that ACE genotype might influence
the severity of the late respiratory complications of mus-
tard gas exposure, and have tested this hypothesis in a
pilot study.
Methods
Thus study was approved by the Ethics Committee of the
Iranian Janbazan [Veterans'] organization. Written
informed consent was obtained from each subject.
Subjects
All were Kurdish civilians and had suffered high-level
mustard gas exposure at Sardasht, Iran on June 29 1987,
as recorded by the Janbazan veterans' organization – the
official center for compensation of war disabled victims.
In keeping with accepted methodologies, those with only
erythema were defined as "low exposure", whilst those
with erythema and edema, vesiculation, scaling, ulcera-
tion, or crusting are categorized as "high exposure" [16].
Using such criteria, 'high exposure' subjects were selected.
Patients were excluded if they had a history of smoking,
heart failure, occupational history of chemical agent expo-
sure or a lung inflammatory disorder of a different origin.
Pulmonary impairment
Spirometric evaluation was performed in September
2005, with forced expiratory volume over 1 second
(FEV1), forced vital capacity (FVC), and the ratio between
them calculated (Multi-Functional Spirometer HI-801,
Chest M.I., INC, Tokyo, Japan). Spirometry was per-
formed according to international guidelines with the best
of three readings recorded.
Genotyping
Five milliliters of EDTA blood was obtained from each
subject, and ACE genotype was determined using three-
primer polymerase chain reaction amplification (PCR)
and subsequent agarose gel electrophoresis, as previously
reported [17]. All gels included a positive heterozygous
control sample, and genotypes were read by two inde-
pendent observers blind to case/control status. Discrepan-
cies were resolved by repeat PCR.
Statistical Analysis
Analysis was performed using Statview 5.0 (Abacus con-
cepts, Inc., Berkeley, CA, USA). Deviation from Hardy-
Weinberg equilibrium was considered using a chi-squared
test. Disease severity was defined according to a median
split of FEV1 % predicted into better or worse lung func-
tion groups. The influence of age, gender and ACE geno-
type on disease severity was tested using binary logistic
regression analysis comparing D homozygotes to other
genotypes. Throughout, a p-value < 0.05 was considered
statistically significant. Data was normally distributed and
results presented as mean ± standard deviation (SD).
Results
Patient Recruitment
Overall, 208 patients were enrolled with a mean age of
46.6 ± 14.4 years, of whom 89 (43%) were female (Table
1). Mean FEV1 % predicted and FVC % predicted were
70.7 ± 21.0 and 74.4 ± 19.3 respectively. Nearly all
reported some respiratory symptoms: 201 (97%) reported
dyspnea, 160 (77%) reported chronic cough, 102 (49%)
hemoptysis, and 128 (61.5%) chronic sputum produc-BMC Pulmonary Medicine 2008, 8:15 http://www.biomedcentral.com/1471-2466/8/15
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tion. On physical examination 50 (24%) had an expira-
tory wheeze, and 12 (5.8%) inspiratory crackles.
For technical reasons, ACE genotype could not be deter-
mined in 1 subject. In the remaining 207 subjects, ACE
genotype distribution was 37 (17.9%) vs 115 (55.6%) vs
55 (26.6%) for II, ID and DD respectively, and was con-
sistent with Hardy-Weinberg equilibrium (p value =
0.11). Neither age nor gender varied significantly between
ACE genotypes.
As a continuous variable, FEV1 % predicted tended to be
higher in association with the D allele 68.03 ± 20.5%,
69.4 ± 21.4% and 74.8 ± 20.1% for II, ID and DD geno-
types respectively (Figure 1) linear trend p = 0.10. Analysis
of FVC % predicted demonstrated higher values for the
DD genotype with FVC % predicted of 74.59 ± 17.2%,
72.9 ± 19.5% and 77.13 ± 20.3% for II, ID and DD geno-
types respectively (ANOVA p = 0.43)
Gender did not appear to have an influence on disease
severity. Mean FEV1 % predicted for males was 71.7 ± 21
and for females 70.0 ± 21. There was no significant asso-
ciation between gender and severity grouping (Chi2 p =
0.43).
Increasing age was associated with reduced FEV1 % pre-
dicted (r2 0.05 p = 0.001). Mean age in the high FEV1 %
predicted group was 43.2 ± 13.2 in comparison with 50.4
± 14.7 in the low FEV1 % predicted group (t test p =
0.0002).
Median FEV1 % predicted was 73 and this was taken as a
cut off between groups demonstrating higher or lower
spirometry readings. (Table 1).
The ACE DD genotype was overrepresented in the better
spirometry group (Chi2 4.9 (p = 0.03) (Table 2). In a logis-
tic regression model including age this became more sig-
nificant (p = 0.011).
The presence or absence of particular symptoms and
signs, or the number of them present was not associated
with genotype.
Discussion
This study is the first to suggest an association between the
Angiotensin Converting Enzyme Insertion/Deletion poly-
morphism and the severity of late respiratory complica-
tions of mustard gas exposure, as measured by FEV1.
33.6% of subjects in the better lung function group carry
the DD-genotype, whereas only 12% in this group carry
the II-genotype.
The finding that the D-allele was over-represented in sub-
jects with less severe late pulmonary impairment follow-
ing exposure to mustard gas might be considered
unexpected given the higher ACE activity associated with
it and the recognized pro-inflammatory and pro-fibrotic
roles of increased RAS activity in the lung. In contrast to
this finding, previous studies have demonstrated associa-
tions of the D-allele with increased severity of pulmonary
sarcoid [18], acute lung injury responses in adults [19],
non-infectious pulmonary complications of bone marrow
transplantation [20] and of esophageal surgery [21], and
Table 2: Median split groups and ACE genotype
ACE II ACE ID ACE DD
FEV1 > 73 13 (12%) 58 (54%) 36 (33.6%) 107
FEV1 < 73 24 (24%) 57 (57%) 19 (19%) 100
All subjects 37 (17.9%) 115 (55.6%) 55 (26.6%) 207
Table 1: Median split group characteristics
Mean age Mean FEV1 % predicted Mean FVC % predicted Gender
All subjects (208) 46.6 ± 14.4 70.7 ± 21.0 74.4 ± 19.3 89 (43%) female
FEV1 > 73 43.2 ± 13.2 86.2 ± 10.9 88.6 ± 13.9 49 (45.8%) female
FEV1 < 73 50.4 ± 14.7 53.9 ± 15.8 62.3 ± 16.9 40 (40%) female
Mean FEV1 % predicted by ACE genotype Figure 1
Mean FEV1 % predicted by ACE genotype. Error bars 
represent Standard error mean (SEM). Test for linear trend p 
= 0.1.
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with the development of bronchopulmonary dysplasia
after premature birth [22].
Recently a study of transbronchial lung biopsies in
patients with severe mustard gas related lung disease has
revealed histopathological changes diagnosable as organ-
izing pneumonia [3,23]. Previously fibrosis had been con-
sidered to be the predominant pathology in the late
respiratory complications of mustard gas exposure. The
pathogenesis of organizing pneumonia may interact with
the RAS in a different way to the generation of fibrosis and
help explain the association of the D-allele with less
severe pulmonary impairment.
Most studies examining the role of the RAS in lung inflam-
mation and fibrosis have associated the I-allele with less
severe disease in the short term response to a pathological
insult. This study examined pulmonary impairment
nearly 20 years after exposure to mustard gas and may sug-
gest that the RAS has a different influence on chronic pul-
monary disease.
Additionally we found the severity of pulmonary impair-
ment following mustard gas exposure to be associated
with increasing age – findings that accord with those of
Zarchi et al, in a study of 1337 soldiers exposed to mus-
tard gas [24]. The mechanism underlying this increased
susceptibility with age is unclear. It could represent a
greater susceptibility at a pulmonary level or could be that
removal of children from exposure (both physically and
the removal of clothing to prevent ongoing exposure)
may have been more effective
A further study is warranted – and one which not only
includes far greater numbers, but which obtains far greater
phenotypic detail – including detailed non-invasive pul-
monary function testing, and imaging.
These findings, and the issue of further study, are of
importance for a number of reasons. Certainly, gene-envi-
ronment studies such as this may prove powerful in
exploring the fundamental mechanisms driving progres-
sive lung pathology of diverse origin. In addition, how-
ever, there are many tens of thousands of patients
suffering the pulmonary sequelae of mustard gas expo-
sure, for whom no specific therapeutic modality is yet
available. The demonstration that ACE influences such
pathology may open the way to new therapeutic options.
Conclusion
ACE genotype influences the severity of the late respira-
tory complications of mustard gas exposure with the D
allele being associated with higher FEV1 % predicted 18
years after exposure.
Abbreviations
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